Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited)

v3.5.0.2
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2016
Sep. 30, 2015
Sep. 30, 2016
Sep. 30, 2015
Income Statement [Abstract]        
Sales $ 922,919 $ 930,686 $ 2,912,152 $ 2,988,503
Cost of sales 622,836 612,916 1,861,148 1,865,380
Gross Profit 300,083 317,770 1,051,004 1,123,123
Operating Expenses        
Selling, general and administrative 389,684 400,984 1,285,145 1,395,856
Research and development 23,527 15,000 69,640 51,000
Total Operating Expenses 413,211 415,984 1,354,785 1,446,856
Loss from Operations (113,128) (98,214) (303,781) (323,733)
Other Income (Expense)        
Interest income 1 2
Interest expense (70,231) (71,893) (204,466) (218,828)
Bad Debt Recovery 1,508
Net gain (loss) on equity method investment (2,362) 31,625 (2,572) 26,972
Total Other Income (Expense) (72,593) (40,267) (205,530) (191,854)
Loss before provision for income taxes (185,721) (138,481) (509,311) (515,587)
Provision for income taxes
Net Loss (185,721) (138,481) (509,311) (515,587)
Preferred Stock Dividends (26,178) (24,294) (78,550) (71,106)
Net Loss Attributable to Common Stockholders $ (211,899) $ (162,775) $ (587,861) $ (586,693)
Loss per Share - Basic and Diluted (in dollars per share) $ (0.01) $ 0.00 $ (0.01) $ (0.02)
Weighted Average Number of Shares - Basic and Diluted (in shares) 36,588,240 36,588,240 36,588,240 36,588,240